Effects of Lactate on Intracellular pH and Hypercontracture During Simulated Ischemia and Reperfusion in Cardiac Ventricular Myocytes of the Guinea Pig.

DOI Web Site Web Site Web Site Web Site ほか1件をすべて表示 一部だけ表示 被引用文献1件 参考文献55件
  • Tokuno Tomoaki
    Department of Pharmacology & Therapeutics, Faculty of Pharmaceutical Sciences, Nagoya City University
  • Watanabe Minoru
    Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Nagoya City University
  • Imaizumi Yuji
    Department of Pharmacology & Therapeutics, Faculty of Pharmaceutical Sciences, Nagoya City University

この論文をさがす

抄録

Effects of lactate on changes in intracellular pH (pHi) and contractility during simulated ischemia and reperfusion were examined in single myocytes of the guinea pig cardiac ventricle. The conditions of simulated ischemia were produced by the exchange of perfusion medium from the standard one oxygenated with 95% O2 - 5% CO2 gas (pH 7.4) to one containing no glucose, 8 mM K+, and 0 - 30 mM sodium-D, L-lactate and was gassed with 90% argon - 10% CO2 (pH 6.6). The pHi was decreased by the simulated ischemia from approx. 7.3 to approx. 6.9 regardless of lactate concentration, while the rate of pHi decrease was increased by lactate in a concentration-dependent manner. The contraction induced by electrical stimulation disappeared faster in the presence of lactate. The incidence of irreversible hypercontracture of myocytes was significantly reduced by 20 - 30 mM lactate. The overshoot of pHi to approx. 7.7 and excess contractions were induced by withdrawal of lactate during the reperfusion, but not observed when lactate was continuously present. The recovery of normal contractility during reperfusion was facilitated by lactate. It can be concluded that lactate added to or removed from the perfusion medium increases the rate of pHi change under the simulated ischemia and reperfusion, respectively, and that the continuous presence of lactate reduces cell injury under these conditions.

収録刊行物

  • Jpn.J.Pharmacol.

    Jpn.J.Pharmacol. 80 (4), 343-350, 1999

    公益社団法人 日本薬理学会

被引用文献 (1)*注記

もっと見る

参考文献 (55)*注記

もっと見る

詳細情報

問題の指摘

ページトップへ